Syncom Formulations (India) Shareholding

Syncom Formulations (India) Ltd Shareholding Pattern

The Syncom Formulations (India) Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Syncom Formulations (India) Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Syncom Formulations (India) Ltd (NSE: SYNCOMF, BSE: 524470) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Syncom Formulations (India) Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Syncom Formulations (India) Ltd Shareholding Pattern (Latest)

The latest Syncom Formulations (India) Ltd shareholding for Mar 2026 is:

• Promoters: 50.57%
• FII: 0.21%
• DII: 0.00%
• Public: 49.21%
• Government: 0.00%

Promoter holding in Syncom Formulations (India) Ltd remains stable, reflecting consistent long-term commitment.

Syncom Formulations (India) Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Syncom Formulations (India) Ltd.

• Mar 2026: 50.57%
• Dec 2025: 50.57%
• Sept 2025: 50.57%
• Jun 2025: 50.57%
• Mar 2025: 50.57%

Promoter stake remains largely stable, showing consistent ownership structure.

Syncom Formulations (India) Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Syncom Formulations (India) Ltd.

• Mar 2026: 0.21%
• Dec 2025: 0.26%
• Sept 2025: 0.10%
• Jun 2025: 0.41%
• Mar 2025: 0.11%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Syncom Formulations (India) Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0.00%
• Dec 2025: 0.00%
• Sept 2025: 0.00%
• Jun 2025: 0.00%
• Mar 2025: 0.00%

DII stake in Syncom Formulations (India) Ltd has increased over time, indicating growing domestic institutional confidence.

Syncom Formulations (India) Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 49.21%
• Dec 2025: 49.17%
• Sept 2025: 49.33%
• Jun 2025: 49.02%
• Mar 2025: 49.32%

Public participation in Syncom Formulations (India) Ltd has increased, indicating rising retail investor interest.

Syncom Formulations (India) Ltd Government Holding

Government holding in Syncom Formulations (India) Ltd currently stands at 0.00%.

Syncom Formulations (India) Ltd operates without significant government ownership.

Syncom Formulations (India) Ltd Shareholding Analysis Summary

The Syncom Formulations (India) Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Syncom Formulations (India) Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Syncom Formulations (India) Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.